MENU
Elicio Therapeutics (ELTX) Ownership - Who owns Elicio Therapeutics?
Profile
Industry
N/A
Address
451 D Street
Phone
+1 857 209-0050
Employees
32
Web
https://www.elicio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
42.56M
P/E Ratio
4.29
Total Cash
3.43M
Projected Growth
N/A
Total Debt
6.42M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ELTX
Capitalization
42.6M
P/E Ratio
4.29
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
3.43M
Total Cash/Share
0.32
Total Debt
6.42M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-1.65M
P/B Ratio
10.02
Cash Flow
N/A
Earnings
0.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
103K
Current Ratio
0.88
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-37.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-144.90
Shares Held By Institutions
4.52M
Shares Outstanding - Current
10.8M
Total Liabilities
17.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-52.638
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
451 D Street
Phone
+1 857 209-0050
Employees
32
Web
https://www.elicio.com